Versant Vantage I, L.P. - Insider Non-Derivative Transactions at Monte Rosa Therapeutics, Inc. (GLUE) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 20, 2024, Versant Vantage I, L.P.'s relationship to Monte Rosa Therapeutics, Inc. (GLUE) is TenPercentOwner, and currently has 5,099,336 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other GLUE insiders.
Data Source: SEC.
Versant Vantage I, L.P. - Insider Non-Derivative Transactions at GLUE
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 21, 2024 | Sell -- (Common Stock) | 1132566 | 6.53 | 5099336 |